David Roman
Stock Analyst at Goldman Sachs
(2.26)
# 2,734
Out of 5,072 analysts
57
Total ratings
46.88%
Success rate
-1.81%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Upgrades: Neutral | $81 → $111 | $105.35 | +5.36% | 2 | Nov 19, 2025 | |
| IRTC iRhythm Technologies | Maintains: Neutral | $180 → $202 | $188.30 | +7.28% | 4 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $94 → $104 | $86.82 | +19.79% | 4 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $25 → $22 | $18.66 | +17.90% | 4 | Oct 31, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $26 → $33 | $31.51 | +4.73% | 3 | Oct 29, 2025 | |
| COO The Cooper Companies | Initiates: Sell | $64 | $78.21 | -18.17% | 1 | Oct 1, 2025 | |
| BLCO Bausch + Lomb | Initiates: Neutral | $16 | $15.89 | +0.69% | 1 | Oct 1, 2025 | |
| GKOS Glaukos | Initiates: Buy | $103 | $104.35 | -1.29% | 1 | Oct 1, 2025 | |
| DOCS Doximity | Downgrades: Sell | $57 → $64 | $51.07 | +25.32% | 4 | Oct 1, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $20 | $15.05 | +32.89% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $14.75 | +28.81% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $18.13 | +59.96% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $104 | $105.44 | -1.37% | 3 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $380 | $328.82 | +15.56% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $97.07 | +7.14% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $7.46 | +34.05% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $79.96 | +2.55% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $24 → $23 | $27.15 | -15.29% | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $128.05 | +20.27% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $21.84 | +9.89% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $85.77 | -17.22% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $63.31 | -13.13% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $375.08 | +13.84% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $101.36 | -11.21% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $578.87 | -13.62% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $195.49 | +40.16% | 1 | May 30, 2024 |
Medtronic
Nov 19, 2025
Upgrades: Neutral
Price Target: $81 → $111
Current: $105.35
Upside: +5.36%
iRhythm Technologies
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $188.30
Upside: +7.28%
Edwards Lifesciences
Oct 31, 2025
Maintains: Buy
Price Target: $94 → $104
Current: $86.82
Upside: +19.79%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $25 → $22
Current: $18.66
Upside: +17.90%
Beta Bionics
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $31.51
Upside: +4.73%
The Cooper Companies
Oct 1, 2025
Initiates: Sell
Price Target: $64
Current: $78.21
Upside: -18.17%
Bausch + Lomb
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $15.89
Upside: +0.69%
Glaukos
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $104.35
Upside: -1.29%
Doximity
Oct 1, 2025
Downgrades: Sell
Price Target: $57 → $64
Current: $51.07
Upside: +25.32%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $15.05
Upside: +32.89%
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $14.75
Upside: +28.81%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $18.13
Upside: +59.96%
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $105.44
Upside: -1.37%
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $328.82
Upside: +15.56%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $97.07
Upside: +7.14%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.46
Upside: +34.05%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $79.96
Upside: +2.55%
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $27.15
Upside: -15.29%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $128.05
Upside: +20.27%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $21.84
Upside: +9.89%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $85.77
Upside: -17.22%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $63.31
Upside: -13.13%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $375.08
Upside: +13.84%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $101.36
Upside: -11.21%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $578.87
Upside: -13.62%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $195.49
Upside: +40.16%